D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension

Elham Ghasemian ¹, Parisa Motaghian ¹, Alireza Vatanara ¹ *

Cited by CrossRef: 19

1- Parrish R, Ashworth L, Löbenberg R, Benavides S, Cies J, MacArthur R. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update. Pharmaceutics. 2022;14(5):1032 [Crossref]

2- Aldeeb R, Mahdy M, El-Nahas H, Musallam A. Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment. Drug Deliv and Transl Res. 2023;13(9):2340 [Crossref]

3- Corrias F, Melis A, Atzei A, Marceddu S, Dedola F, Sirigu A, Pireddu R, Lai F, Angioni A. Zoxamide accumulation and retention evaluation after nanosuspension technology application in tomato plant. Pest Management Science. 2021;77(7):3508 [Crossref]

4- Sakr R, Abdelaziz A, Mazyed E, El Maghraby G. Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers. Sci Rep. 2024;14(1) [Crossref]

5- Indrati O, Martien R, Rohman A, Nugroho A. Development of nanoemulsion-based hydrogel containing andrographolide: physical properties and stability evaluation. J Pharm Bioall Sci. 2020;12(6):816 [Crossref]

6- Al-Ansari D, Mohamed N, Marei I, Zekri A, Kameno Y, Davies R, Lickiss P, Rahman M, Abou-Saleh H. Internalization of Metal–Organic Framework Nanoparticles in Human Vascular Cells: Implications for Cardiovascular Disease Therapy. Nanomaterials. 2020;10(6):1028 [Crossref]

7- Babaei M, Shayanfar A, Rahimpour E, Barzegar-Jalali M, Martinez F, Jouyban A. Solubility of bosentan in {propylene glycol + water} mixtures at various temperatures: experimental data and mathematical modelling. Physics and Chemistry of Liquids. 2019;57(3):338 [Crossref]

8- Deng Y, Zhang X, Shen H, He Q, Wu Z, Liao W, Yuan M. Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases. Front Bioeng Biotechnol. 2020;7 [Crossref]

9- Yang F, Xue J, Wang G, Diao Q. Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Front Pharmacol. 2022;13 [Crossref]

10- Moisa S, Burlacu A, Butnariu L, Vasile C, Brinza C, Spoiala E, Maștaleru A, Leon M, Rosu S, Vatasescu R, Cinteză E. Nanotechnology Innovations in Pediatric Cardiology and Cardiovascular Medicine: A Comprehensive Review. Biomedicines. 2024;12(1):185 [Crossref]

11- Martín Giménez V, Kassuha D, Manucha W. Nanomedicine applied to cardiovascular diseases: latest developments. Therapeutic Advances in Cardiovascular Disease. 2017;11(4):133 [Crossref]

12- Przybyłek M, Jeliński T, Cysewski P. Application of Multivariate Adaptive Regression Splines (MARSplines) for Predicting Hansen Solubility Parameters Based on 1D and 2D Molecular Descriptors Computed from SMILES String. Journal of Chemistry. 2019;2019:1 [Crossref]

13- Minecka A, Chmiel K, Jurkiewicz K, Hachuła B, Łunio R, Żakowiecki D, Hyla K, Milanowski B, Koperwas K, Kamiński K, Paluch M, Kamińska E. Studies on the Vitrified and Cryomilled Bosentan. Mol Pharmaceutics. 2022;19(1):80 [Crossref]

14- Shi W. Application of Multifunctional Nanomaterials Combined with Sports Rehabilitation Training in the Diagnosis and Treatment of Cardiovascular Diseases. Integrated Ferroelectrics. 2021;216(1):81 [Crossref]